HBGIX
Price
$24.58
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
3.09B
VFIAX
Price
$703.50
Change
+$0.93 (+0.13%)
Updated
Jun 2 closing price
Net Assets
1.6T
Interact to see
Advertisement

HBGIX vs VFIAX

Header iconHBGIX vs VFIAX Comparison
Open Charts HBGIX vs VFIAXBanner chart's image
HBGIX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
HBGIX vs. VFIAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBGIX is a Buy and VFIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.6T vs. HBGIX (3.09B). VFIAX pays higher dividends than HBGIX: VFIAX (1.02) vs HBGIX (0.14). HBGIX was incepted earlier than VFIAX: HBGIX (28 years) vs VFIAX (26 years). HBGIX (0.85) is less costly to investors than VFIAX (0.04). HBGIX is a more actively managed with annual turnover of: 35.00 vs. VFIAX (2.00). HBGIX has a lower initial minimum investment than VFIAX: HBGIX (0) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 28.07 vs. HBGIX (10.50). VFIAX return over 5 years is better than : 81.36 vs. HBGIX (31.91).
HBGIXVFIAXHBGIX / VFIAX
Total Expense Ratio0.850.042,125%
Annual Report Gross Expense Ratio0.850.042,125%
Fund Existence28 years26 years-
Gain YTD8.28211.20474%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.09B1.6T0%
Annual Yield % from dividends0.141.0214%
Returns for 1 year10.5028.0737%
Returns for 3 years46.7477.5860%
Returns for 5 years31.9181.3639%
Returns for 10 years63.23262.1024%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRMEP25.120.02
+0.08%
First Merchants Corp
FTEK1.48-0.01
-0.34%
Fuel Tech
TSLX17.88-0.12
-0.67%
Sixth Street Specialty Lending
PRI260.02-6.57
-2.46%
PRIMERICA
LXEO4.50-0.31
-6.44%
Lexeo Therapeutics